Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP659646.RAcZ_pUbq5S8EwqqD2fvq4935d4fUV239zy1bvQ0ChXdE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP659646.RAcZ_pUbq5S8EwqqD2fvq4935d4fUV239zy1bvQ0ChXdE130_assertion type Assertion NP659646.RAcZ_pUbq5S8EwqqD2fvq4935d4fUV239zy1bvQ0ChXdE130_head.
- NP659646.RAcZ_pUbq5S8EwqqD2fvq4935d4fUV239zy1bvQ0ChXdE130_assertion description "[We have previously reported that systemic blockade of IL-1beta in patients with type 2 diabetes with anakinra (a recombinant human interleukin-1-receptor antagonist, IL-1Ra), lowered glycated hemoglobin improved beta-cell function and reduced circulating levels of IL-6 and CRP (7).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP659646.RAcZ_pUbq5S8EwqqD2fvq4935d4fUV239zy1bvQ0ChXdE130_provenance.
- NP659646.RAcZ_pUbq5S8EwqqD2fvq4935d4fUV239zy1bvQ0ChXdE130_assertion evidence source_evidence_literature NP659646.RAcZ_pUbq5S8EwqqD2fvq4935d4fUV239zy1bvQ0ChXdE130_provenance.
- NP659646.RAcZ_pUbq5S8EwqqD2fvq4935d4fUV239zy1bvQ0ChXdE130_assertion SIO_000772 19541594 NP659646.RAcZ_pUbq5S8EwqqD2fvq4935d4fUV239zy1bvQ0ChXdE130_provenance.
- NP659646.RAcZ_pUbq5S8EwqqD2fvq4935d4fUV239zy1bvQ0ChXdE130_assertion wasDerivedFrom befree-20140225 NP659646.RAcZ_pUbq5S8EwqqD2fvq4935d4fUV239zy1bvQ0ChXdE130_provenance.
- NP659646.RAcZ_pUbq5S8EwqqD2fvq4935d4fUV239zy1bvQ0ChXdE130_assertion wasGeneratedBy ECO_0000203 NP659646.RAcZ_pUbq5S8EwqqD2fvq4935d4fUV239zy1bvQ0ChXdE130_provenance.